No mutations found by RET mutation scanning in sporadic and hereditary neuroblastoma

作者: Robert M. W. Hofstra , Rein P. Stulp , Tineke Stelwagen , Charles H. C. M. Buys , Ngan Ching Cheng

DOI: 10.1007/BF02185773

关键词:

摘要: Neuroblastoma occasionally occurs in diseases associated with abnormal neurocrest differentiation, e.g. Hirschsprung disease. Expression studies developing mice suggest that the proto-oncogeneRET plays a role differentiation. In humans expression ofRET is limited to certain tumor types, including neuroblastoma, derive from migrating neural crest cells. Mutations are found These data prompted us investigate and search for gene mutations neuroblastoma. Out of 16 neuroblastoma cell lines analyzed, 9 show clear Northern blot analysis. single-strand conformation polymorphism (SSCP) analysis all exons, no were detected other than neutral polymorphisms. patient family which different neurocrestopathies, disease, had occurred, we also failed detect RET mutations. Possibly, merely reflects differentiation status The absence suggests thatRET does not play crucial tumorigenesis

参考文章(31)
Bocciardi R, Ceccherini I, Hofstra Rm, Stelwagen T, Nijveen H, Stulp Rp, Luo Y, Seri M, Barone, Bolino A, DNA polymorphisms and conditions for SSCP analysis of the 20 exons of the ret proto-oncogene. Oncogene. ,vol. 9, pp. 3025- 3029 ,(1994)
F. Speleman, H. Caron, R. Versteeg, N. van Roy, A. Westerveld, J. de Kraker, P. A. Voûte, R. Slater, P. van Sluis, Recurrent 1;17 translocations in human neuroblastoma reveal nonhomologous mitotic recombination during the S/G2 phase as a novel mechanism for loss of heterozygosity. American Journal of Human Genetics. ,vol. 55, pp. 341- 347 ,(1994)
L. Savelyeva, R. Corvi, Manfred Schwab, Translocation involving 1p and 17q is a recurrent genetic alteration of human neuroblastoma cells American Journal of Human Genetics. ,vol. 55, pp. 334- 340 ,(1994)
June L. Biedler, Barbara A. Spengler, Lawrence Helson, Morphology and Growth, Tumorigenicity, and Cytogenetics of Human Neuroblastoma Cells in Continuous Culture Cancer Research. ,vol. 33, pp. 2643- 2652 ,(1973)
Minako Nagao, Yukihito Ishizaka, Akira Nakagawara, Kimitoshi Kohno, Michihiko Kuwano, Tomoko Tahira, Fumio Itoh, Isuzu Ikeda, Takashi Sugimura, Expression ofretProto-oncogene in Human Neuroblastomas Japanese Journal of Cancer Research. ,vol. 81, pp. 309- 312 ,(1990) , 10.1111/J.1349-7006.1990.TB02566.X
G. M. Brodeur, G. S. Sekhon, M. N. Goldstein, Chromosomal aberrations in human neuroblastomas. Cancer. ,vol. 40, pp. 2256- 2263 ,(1977) , 10.1002/1097-0142(197711)40:5<2256::AID-CNCR2820400536>3.0.CO;2-1
Giovanni Romeo, Patrizia Ronchetto, Yin Luo, Virginia Barone, Marco Seri, Isabella Ceccherini, Barbara Pasini, Renata Bocciardi, Margherita Lerone, Helena Kääriäinen, Giuseppe Martucciello, Point mutations affecting the tyrosine kinase domain of the RET proto-oncogene in Hirschsprung's disease Nature. ,vol. 367, pp. 377- 378 ,(1994) , 10.1038/367377A0
Huib Caron, Peter van Sluis, Melanie van Hoeve, Jan de Kraker, Johannes Bras, Rosalyn Slater, Marcel Mannens, P.A. Voûte, Andries Westerveld, Rogier Versteeg, Allelic loss of chromosome 1p36 in neuroblastoma is of preferential maternal origin and correlates with N-myc amplification. Nature Genetics. ,vol. 4, pp. 187- 190 ,(1993) , 10.1038/NG0693-187
C. T. Fong, N. C. Dracopoli, P. S. White, P. T. Merrill, R. C. Griffith, D. E. Housman, G. M. Brodeur, Loss of heterozygosity for the short arm of chromosome 1 in human neuroblastomas: correlation with N-myc amplification. Proceedings of the National Academy of Sciences of the United States of America. ,vol. 86, pp. 3753- 3757 ,(1989) , 10.1073/PNAS.86.10.3753
T Iwamoto, M Taniguchi, W Wajjwalku, I Nakashima, M Takahashi, Neuroblastoma in a transgenic mouse carrying a metallothionein/ ret fusion gene British Journal of Cancer. ,vol. 67, pp. 504- 507 ,(1993) , 10.1038/BJC.1993.94